Refractory Hodgkin lymphoma responds to pentostatin (2'-deoxycoformycin).
Braiteh
Fadi
F
Ng
Chaan
C
Kurzrock
Razelle
R
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D006689:Hodgkin Disease / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D009367:Neoplasm Staging; D015649:Pentostatin / Q000627:therapeutic use*; D049268:Positron-Emission Tomography / Q000379:methods; D012008:Recurrence; D012074:Remission Induction; D012680:Sensitivity and Specificity; D014182:Transplantation, Autologous; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D015649:Pentostatin